Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk

NCT00017134 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

71

Enrollment

NETWORK

Sponsor class

Stopped Withdrawn due to poor accrual

Conditions

Ovarian Cancer

Interventions

DRUG: fenretinide
PROCEDURE: conventional surgery

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]